Prosight Management, LP Amicus Therapeutics, Inc. Transaction History
Prosight Management, LP
- $281 Million
- Q1 2025
A detailed history of Prosight Management, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 1,379,383 shares of FOLD stock, worth $8.32 Million. This represents 4.01% of its overall portfolio holdings.
Number of Shares
1,379,383
Previous 920,000
49.93%
Holding current value
$8.32 Million
Previous $8.67 Million
29.88%
% of portfolio
4.01%
Previous 2.57%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$176 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$175 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$147 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$129 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$124 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.69B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...